Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03226210
What this trial is testing

Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Nanjing First Hospital, Nanjing Medical University 110
Testing effectiveness (Phase 2)Study completedNCT01697618
What this trial is testing

Pharmacokinetics, Pharmacodynamics and Safety of Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 13
Not applicableStudy completedNCT00834262
What this trial is testing

Observational Study on Safety and Efficacy of Biphasic Insulin Aspart in Type 2 Diabetes Patients

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 339
Large-scale testing (Phase 3)Study completedNCT07560150
What this trial is testing

Comparison of the Pharmacokinetics (PK) and Pharmacodynamics (PD) Biosimilarity of Proposed Biosimilar/Interchangeable Rapid-Acting Insulin Aspart (I004) and NovoLog® After Single-Dose Subcutaneous Administration to Healthy Volunteers

Who this might be right for
PharmacokineticsPharmacodynamicsInsulin Aspart
Amphastar Pharmaceuticals, Inc. 62
Early research (Phase 1)Study completedNCT00824668
What this trial is testing

Comparison of Pharmacodynamics and Pharmacokinetics of Biphasic Insulin Aspart 30 and Insulin Glargine and Insulin Glulisine Therapy in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 24
Early research (Phase 1)Study completedNCT01868568
What this trial is testing

Comparison of IDegAsp (Inclusive Three Explorative Formulations) With Insulin Degludec and Insulin Aspart Separately Injected in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 55
Post-approval studies (Phase 4)Study completedNCT00965549
What this trial is testing

Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 463
Early research (Phase 1)Study completedNCT01527552
What this trial is testing

Bioequivalence of Two Formulations of Biphasic Insulin Aspart 50 in Healthy Male Subjects

Who this might be right for
DiabetesHealthy
Novo Nordisk A/S 30
Post-approval studies (Phase 4)UnknownNCT04414579
What this trial is testing

The Efficacy and Safety of Faster Insulin Aspart (Fiasp®) Compared to Conventional Insulin Aspart (NovoLog®) as Correction Bolus

Who this might be right for
Type 1 Diabetes Mellitus
Mountain Diabetes and Endocrine Center 45
Early research (Phase 1)Study completedNCT02594033
What this trial is testing

A Trial to Investigate Different Needle Features Assessed by Comparing Insulin Aspart Pharmacokinetic Profiles

Who this might be right for
Diabetes
Novo Nordisk A/S 46
Post-approval studies (Phase 4)Study completedNCT00384085
What this trial is testing

Insulin Glargine "All to Target" Trial

Who this might be right for
Diabetes Mellitus, Type 2
Sanofi 588
Post-approval studies (Phase 4)Study completedNCT01215435
What this trial is testing

Comparison of Two Biphasic Insulin Aspart 30 Treatment Regimens in Subjects With Type 2 Diabetes Not Achieving HbA1c Treatment Targets on OADs Alone

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 245
Large-scale testing (Phase 3)Study completedNCT01513473
What this trial is testing

A Trial Investigating the Efficacy and Safety of Insulin Degludec in Children and Adolescents With Type 1 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 350
Large-scale testing (Phase 3)Study completedNCT04588259
What this trial is testing

Research Study to Compare a New Medicine "Fast-acting Insulin Aspart" to Another Medicine "Insulin Aspart" in Chinese People With Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 331
Large-scale testing (Phase 3)Study completedNCT00564668
What this trial is testing

Comparison of Biphasic Insulin Aspart Produced by the NN2000 Process to Current Process to in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 126
Post-approval studies (Phase 4)Study completedNCT01892020
What this trial is testing

Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 161
Post-approval studies (Phase 4)Study completedNCT01486862
What this trial is testing

Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 26
Testing effectiveness (Phase 2)Study completedNCT00841087
What this trial is testing

Comparison of NN1250 Versus Insulin Detemir, Both Combined With Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 65
Large-scale testing (Phase 3)Study completedNCT05013229
What this trial is testing

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Insulin Glargine Taken Daily With Insulin Aspart (COMBINE 3)

Who this might be right for
Diabetes Mellitus, Type 2
Novo Nordisk A/S 679
Not applicableStudy completedNCT03987802
What this trial is testing

An Indian Post Marketing Study of Mealtime Insulin, Fiasp®, to Evaluate Its Safety and Effectiveness in Patients With Diabetes Mellitus in Routine Clinical Practice

Who this might be right for
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 42
Next Page